English | Español
Patient Daily | Apr 16, 2026

Study finds minimal academic impact from prenatal opioid exposure after controlling for environment
Patient Daily | Apr 16, 2026

Barnsley audiologist Rebecca Jenkins to run London Marathon for Hearing Dogs charity
Patient Daily | Apr 16, 2026

BioSpace leaders discuss Q1 2026 job market trends and outlook
Patient Daily | Apr 16, 2026

Eli Lilly acquires CrossBridge Bio in $300 million deal for cancer drug development
Patient Daily | Apr 16, 2026

FDA urges over 2,200 drug developers to publish clinical trial results
Patient Daily | Apr 16, 2026

FDA approves Filspari as first treatment for rare kidney disease FSGS
Patient Daily | Apr 16, 2026

Patient-centric approach seen as key advantage in drug development, says Parexel executive
Patient Daily | Apr 16, 2026

Lilly announces major investments in China and Japan for oral GLP-1 production

Trending
Patient Daily | Apr 23, 2026

Taxpayers Protection Alliance director says 340B program raises costs for patients and taxpayers
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Roche and C4 Therapeutics announce new molecular glue partnership worth up to $1 billion
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Insmed ends skin disease drug development after trial results fall short
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Bristol Myers Squibb spinout Beeline Medicines launches with $300 million and five assets